Patients who took Onglyza (saxagliptin) for their Type 2 diabetes may have experienced a higher risk of heart failure. Your law firm could be reaching out to these clients, who may have grounds for a lawsuit against Onglyza's manufacturer, AstraZeneca. Gacovino Lake is a New York law firm offering co-counseling and support to other law firms looking to diversify their case portfolio or better manage their leads. Visit our co-counseling website at lawfirm2lawfirm.com or our law firm website at gacovinolake.com

1. What Attorneys
Need to Know
About Onglyza
Lawsuits
270 West Main Street
Sayville, NY 11782
1-888-LAW-8500

2. About the Authors
Steven Gacovino &
Edward Lake met
at Touro College
Law Center.
Graduated in 1992
and established
firm the following
year.
Gacovino Lake has
successfully
litigated over
20,000 cases. We
have more than 20
years mass tort
experience.
Experience in
marketing, lead
generation, and
contract follow-up.
We work with top
trial firms in the
country.

3. What is Onglyza?
▪ Prescription name for saxagliptin.
▪ Type 2 diabetes medication.

4. 2008:
FDA announced
recommendation for all
new type 2 diabetes
drugs.

5. FDA Regulations
▪ Drug makers must prove no link to
significant increase in cardiovascular
(CV) events risk.
▫ Any increase in risk must be < 30%.

6. 27%
SAVOR Study: saxagliptin (Onglyza) may increase risk
of hospitalization for heart failure by
Source: Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., ... & Cavender, M. A. (2013). Saxagliptin and
cardiovascular outcomes in patients with type 2 diabetes mellitus. New England Journal of Medicine, 369(14), 1317-1326.
(http://www.nejm.org/doi/full/10.1056/NEJMoa1307684#t=articleTop)

7. 2015:
Endocrinologic and
Metabolic Drugs Advisory
Committee (EMDAC)
voted on new warning
label for Onglyza.

8. New Warning Label
▪ EMDAC voted 13 to 1 (1 abstained) that
Onglyza met standards.
▫ 14 of 15 members recommended updating label with
heart failure warning.
▫ 1 voted to remove Onglyza from market.

9. Onglyza Lawsuits
▪ At least one lawsuit currently filed
against AstraZeneca.
▫ Alleges patient died from heart failure after taking
drug for three years.
▫ Patient hospitalized twice before death.

10. Invest in Onglyza
Cases
▪ National mass tort law firms
advertising for cases.
▪ No class action filed; individual claims
still viable.
▪ SAVOR study data supports increased
risk of CV events.

11. Invest in Onglyza
Cases
▪ Allegations Onglyza increases pancreatitis
risk, potentially pancreatic cancer.
▪ Further research may lead to additional
litigation.

12. 1. Our firm retains the case
using your retainer.
Two Ways to Work
With Gacovino Lake
2. In exchange for
participation fee, we
connect you to a trial firm
we work with.

13. Two Ways to Contact Us
Phone: 1-888-LAW-8500.
Contact page
Presentation template by SlidesCarnival